ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

SYRE Spyre Therapeutics Inc

34.95
0.90 (2.64%)
2024年6月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Spyre Therapeutics Inc SYRE NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.90 2.64% 34.95 09:00:00
始値 安値 高値 終値 前日終値
34.45 34.13 35.83 34.95 34.05
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/3105:33EDGAR2Form 8-K - Current report
2024/5/2921:30PRNUSSpyre Therapeutics to Participate in the Jefferies Global..
2024/5/1705:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1705:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1705:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1705:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1705:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1705:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/5/1520:40EDGAR2Form 8-K - Current report
2024/5/1520:30PRNUSSpyre Therapeutics Appoints Accomplished Biopharma Leader..
2024/5/1005:11EDGAR2Form 8-K - Current report
2024/5/1005:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1005:02PRNUSSpyre Therapeutics Reports First Quarter 2024 Financial..
2024/5/0406:00PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
2024/4/0206:00PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
2024/3/1821:00PRNUSSpyre Therapeutics Announces $180 Million Private Placement
2024/3/0607:15EDGAR2Form POS AM - Post-Effective amendments for registration..
2024/3/0207:25PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
2024/3/0120:14EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2024/3/0107:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0106:14EDGAR2Form 8-K - Current report
2024/3/0106:05PRNUSSpyre Therapeutics Reports Fourth Quarter and Full Year 2023..
2024/2/2621:30PRNUSSpyre Therapeutics to Participate in the 44th Annual TD..
2024/2/2111:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1510:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1505:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1422:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1408:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1406:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0821:30PRNUSSpyre Therapeutics Announces Three Abstracts Accepted for..
2024/2/0607:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0607:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/2/0521:36EDGAR2Form 8-K - Current report
2024/2/0521:30PRNUSSpyre Therapeutics Appoints Accomplished Biopharma and IBD..
2024/2/0310:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0310:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0310:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0307:30PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
2024/1/1906:26EDGAR2Form 8-K - Current report
2023/12/3007:00EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/12/3007:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2711:56EDGAR2Form D - Notice of Exempt Offering of Securities
2023/12/2308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2307:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/12/2307:00PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
2023/12/2306:32EDGAR2Form S-1 - General form for registration of securities under..
2023/12/1207:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1207:21EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/12/0906:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

最近閲覧した銘柄

Delayed Upgrade Clock